DCLA
CLX icon

Douglas C. Lane & Associates’s Clorox CLX Stock Holding History

Douglas C. Lane & Associates’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$279K Buy
2,202
+400
+22% +$49.6K 0.01% 195
2015
Q3 		$208K Buy
+1,802
New +$202K 0.01% 223
2015
Q2 		– Sell
-1,902
Closed -$210K – 234
2015
Q1 		$210K Sell
1,902
-100
-5% -$10.9K 0.01% 224
2014
Q4 		$209K Sell
2,002
-125
-6% -$12.5K 0.01% 219
2014
Q3 		$204K Buy
+2,127
New +$192K 0.01% 214
2014
Q1 		– Sell
-2,712
Closed -$252K – 219
2013
Q4 		$252K Sell
2,712
-500
-16% -$45K 0.01% 177
2013
Q3 		$262K Buy
+3,212
New +$271K 0.01% 169

Other funds holding CLX

LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CRC
Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Douglas C. Lane & Associates's CLX Position: Q4 2015 in Review

Douglas C. Lane & Associates increased its Clorox (CLX) stake by 22% in Q4 2015, buying an estimated $49.6K and bringing the position to 2,202 shares worth $279K. The position accounts for 0.01% of the portfolio, ranked #195.

Douglas C. Lane & Associates first reported a position in CLX in Q3 2013 and has held it in 7 quarters since. 830 funds tracked by Wall St. Rank hold CLX as of Q4 2015.

  • Douglas C. Lane & Associates held 2,202 shares of Clorox worth $279K as of Q4 2015.
  • Douglas C. Lane & Associates bought 400 Clorox shares in Q4 2015, an estimated $49.6K.
  • Clorox made up 0.01% of Douglas C. Lane & Associates's portfolio in Q4 2015, its #195 holding.
  • Douglas C. Lane & Associates first reported a position in Clorox in Q3 2013 and has held it in 7 quarters since.
  • 830 funds tracked by Wall St. Rank held Clorox as of Q4 2015.

Based on Douglas C. Lane & Associates's 13F filing for Q4 2015, filed 25 Jan 2016.